Main Sector of relevance\IRC classification 10. Other Industrial Manufacturing Technologies
10.12 LEICLADIN – pharmaceutical substance and medical drug
Developers’ contact information
State Scientific Institution “The Institute of Bioorganic Chemistry of the National Academy of Sciences of Belarus”
5, bldg. 2, Kuprevich Str., 220141 Minsk
Summary
Leicladin is one of the most effective medical drugs used for hairy cell leukemia treatment
Description
The original technology of chemosynthesis of the substance is protected by patent for invention of the Republic of Belarus No. 5602
Technology type
Technical advantages and economic benefits
LEICLADIN is one of the most effective medical drugs used for hairy cell leukemia treatment. The original and extremely effective technology of producing the substance and drug products of LEICLADIN meets the world standards. The original method of synthesis makes it possible to obtain a substance of pharmacopeial purity (more than 99.6%) with high yields. The drug is not produced on the territory of CIS countries. The developed technology allows reducing the drug price in 4 times in comparison with foreign analogues.
Technology differentiation and uniqueness
The original high-technology synthesis scheme
Context in which technology was identified
International Specialized Exhibition “Chemistry. Oil and Gas” 2006, 2008; National exhibition of the Republic of Belarus in the Bolivarian Republic of Venezuela “Expo Feria “BELARUS-2007”
Technological keywords
Anticancer drug, hairy cell leukemia.
Development Stage
Intellectual property rights
Range of applications
—
Classifier Used at the EU Innovation Relay Centres
Preferable Regions
Practical experience
Introduction of the technology in production
Environmental impact
None.
Type of collaboration sought
Terms and restrictions
Terms of the license contract.
Available technical assistance